Stock Events

Stock Events

Avalo Therapeutics (C6K0.STU) Q1 2026 Earnings

23MarConfirmed

Q1 2026

-1.26

-1.05

-0.85

-0.65

Details

Expected EPS

-1.256051588

Actual EPS

-0.6458999999999999

Surprise EPS

0.61

Surprise Percent

+48.58%

Description

Avalo Therapeutics (C6K0.STU) has reported earnings of -0.6458999999999999 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.